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A Fatal Case of Brainstem Encephalitis Caused
by Human Parechovirus
MM YAU, Q MOK, P PRABHAKAR
Abstract There is increasing recognition of human parechovirus (HPeV) as a neurotropic virus, especially type 3,
which can cause sepsis and encephalitis in young infants. We present a case of neonatal brainstem
encephalitis caused by HPeV and review the fifteen published cases in the literature. This is the first
report of HPeV causing brainstem encephalitis. Earlier use of polymerase chain reaction testing for HPeV
should be considered in appropriate cases.
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Introduction
Human parechovirus (HPeV) is a single-stranded non-
enveloped RNA virus belonging to the picornaviridae
family. HPeV 1 and 2, previously named echovirus 22 and
23, were discovered in 1961. HPeV type 3 was first reported
in Japan in 2004, when it was isolated in the stools of an
infant with transient paralysis.1. Subsequently more types
of HPeV have been identified. To our knowledge, this is
the first case of neonatal brainstem encephalitis caused by
HPeV in the literature.
Case Study
A female baby was born in good condition weighing
2.64 kg to non-consanguineous Somali parents. An
emergency Caesarean section was performed for maternal
pyrexia at 36 weeks gestation. Maternal high vaginal swab
was positive for group B Streptococcus, and the baby was
treated for one week with parenteral antibiotics. There was
no significant family history of neurological or metabolic
diseases. She subsequently presented at three weeks of age
with a 24 hour history of poor feeding, irritability, seizures
and apnoea. On admission, she was hypothermic (32
degrees Celsius) and hypotensive. She received fluid
resuscitation and was intubated, ventilated, and transferred
to Neonatal Intensive Care Unit (NICU), Great Ormond
Street Hospital for Children, London.  
She was treated for presumed neonatal sepsis with
parenteral antimicrobials and acyclovir, as well as inotropes
for cardiovascular instability. She was commenced on
maintenance phenobarbitone for seizures, with levels within
therapeutic range. The initial workup for infective aetiology
did not identify a specific cause. Lumbar puncture was a
slight traumatic tap. Cerebrospinal fluid (CSF) examination
showed total white cell count of 25 x 106/L, with 100%
lymphocytes, and red cell count of 250 x 106/L, CSF protein
was raised at 1.7 g/dL. CSF and serum glucose were normal.
1
2
xxx2 3
It was negative for cytomegalovirus DNA, enterovirus RNA,
herpes simplex virus DNA by PCR. Bacterial cultures from
CSF, blood, throat swab and stool were negative.
Nasopharyngeal aspirate polymerase chain reaction (PCR)
for rhinovirus 1 and 2, parainfluenza 1, 2 and 3, influenza
A/B, Respiratory Syncytial Virus, human metapneumovirus,
adenovirus and enterovirus were negative. Blood for
Epstein-Barr virus viral capsid antigen immunoglobulin G
was negative. Extensive metabolic screening was negative.
Sedatives were weaned off following cardiovascular
stabilisation but she had very little spontaneous movement,
no respiratory effort and bilateral pinpoint pupils.
There was no improvement after a trial of naloxone.
Electroencephalogram (EEG) at that time showed generally
low amplitude but no evidence of encephalopathy or
epileptic discharges. Magnetic resonance imaging (MRI)
of the brain on day 3 of admission showed marked signal
abnormality in white matter and swelling in the brainstem
and upper cervical cord, with restricted diffusion,
compatible with encephalitis (Figure 1). Somatosensory
evoked potentials (SSEPs) performed on day 7 of admission
obtained a response from cervical cord but no cortical
response, indicating a severe disorder of brainstem function.
Blinking, corneal and gag reflexes were absent. Deep
tendon reflexes were present. Repeated EEG showed
frequent epileptiform discharges, and phenobarbitone was
continued. Nerve conduction study and electromyography
(EMG) showed normal conduction in legs, but motor and
sensory studies were affected in the arms and her tongue
was denervated. A second MRI brain scan on day 11
of admission showed resolving oedema with gliotic
changes in the brainstem (Figure 1). A course of pulsed
methylprednisolone and intravenous immunoglobulin
did not result in any improvement. Further virological
investigations were carried out, including a test for HPeV
PCR in CSF, which was positive. The parechovirus RNA
assay was developed in-house at Micropathology Ltd. Its
target is the 5' UTR gene of HPeV type 1 to 6. It is a nested
RT-PCR assay and the second round is performed on a
realtime PCR device (Roche LightCycler) using Sybr Green
and melting curve analysis as the detection method.   
Her neurological state remained unchanged with absent
brainstem reflexes and ventilator dependency. A third MRI
brain scan on day 23 of admission showed a gliotic scar
over the brainstem with resolution of edematous changes
(Figure 1). EEG at that time showed decrease in the
epileptiform discharges. SSEPs showed no response from
the cord and cortical area. EMG showed denervation. Visual
evoked potentials and electroretinography were normal.
Clinical ethics and multidisciplinary team meeting was
arranged to discuss withdrawal of care. Her treatment care
was subsequently withdrawn and she passed away
afterwards.
Discussion 
HPeV infections most commonly are enteric and
respiratory, but sepsis, meningitis, encephalitis and hepatitis
have been described.2 More severe diseases in the neonates
comprising sepsis and encephalitis are associated with the
recently emerged HPeV type 3.3 Almost all reported cases
of HPeV encephalitis that were typed were due to type 3.4,5
In 1989, Koskiniemi et al presented a case of severe
encephalitis caused by HPeV 1.6 Subsequently, fifteen more
cases of HPeV encephalitis have been reported.4,5,7-9
Presenting symptoms are non-specific such as fever,
irritability, seizure, apnoea and sepsis-like picture. MRI
brain scans show particular patterns affecting white matter
in internal capsule, periventricular area, corpus callosum,
optic radiation and cerebral peduncles. Punctate lesions are
also identified. The findings are derived from infection with
different subtypes of human parechoviruses. Diagnosis is
mainly by HPeV PCR in CSF. These children have variable
prognoses (Table 1).
Its neurotropic property is further supported by Harvala
et al who reported a predilection of HPeV type 3 to cause
CNS infections in young infants.2 Similar result was found
by Benshop et al. It had been postulated that the use of
different cellular receptors may be the reason explaining
the neurotropic property of HPeV type 3.11 The exact reason
why neonates are susceptible to HPeV type 3 is not known.
Ito et al found that only 56.5-73.9% of adults of child
bearing age were seropositive for HPeV type 3, in contrast
to 97% seropositivity of HPeV type 1.1 Lack of protective
transplacental antibodies may well pose a high risk to
neonates. Prospective studies on the prevalence would be
very useful in understanding the impact of this virus.
Diagnosis of viral encephalitis in the neonatal period
can be challenging as the immune and inflammatory
response especially in the CSF might not be present. Herpes
simplex virus and cytomegalovirus are readily treated in
neonatal CNS infection. Wolthers et al analysed 716 CSF
samples in young children previously tested for enterovirus
PCR. They found that the addition of a virus-specific PCR
led to a 31% increase in detection of a viral cause of neonatal
sepsis or central nervous system symptoms in children aged
<5 years. They concluded that HPeV could be the second
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Figure 1 (a) Diffusion-weighted image of MRI on day 3 showing restricted diffusion over the brainstem. (b) Coronal image of MRI on
day 3 showing oedematous change in brainstem and upper cervical cord. (c) Coronal image of MRI on day 23 showing gliotic changes in
previous oedematous areas.
(a) (b) (c)
most common cause of viral sepsis and meningitis in young
children.3 Early and accurate diagnosis can potentially lead
to shortening the duration of antimicrobial and antiviral
treatment.
Although there is no proven treatment for HPeV
infection, accurate diagnosis and characterisation of HPeV
infection is an important first step to a clearer understanding
of its pathophysiology and eventually more effective
treatments. From this case presented we would recommend
earlier testing for HPeV by PCR in neonatal encephalitis
of unknown origin.
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